Anne Gussow

Array ( [id] => 7055988 [patent_doc_number] => 20050277162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Detection and modulation of cancer stem cells' [patent_app_type] => utility [patent_app_number] => 11/148149 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27935 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277162.pdf [firstpage_image] =>[orig_patent_app_number] => 11148149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712755 [patent_doc_number] => 08093361 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Anti-perp antibody' [patent_app_type] => utility [patent_app_number] => 11/628745 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 38047 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093361.pdf [firstpage_image] =>[orig_patent_app_number] => 11628745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069025 [patent_doc_number] => 20050244408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Antibodies to insulin-like growth factor I receptor' [patent_app_type] => utility [patent_app_number] => 11/144248 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 36289 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244408.pdf [firstpage_image] =>[orig_patent_app_number] => 11144248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599128 [patent_doc_number] => 07977071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Binding moieties based on shark ignar domains' [patent_app_type] => utility [patent_app_number] => 11/628475 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 62 [patent_no_of_words] => 175079 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977071.pdf [firstpage_image] =>[orig_patent_app_number] => 11628475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7068952 [patent_doc_number] => 20050244335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Methods and compositions related to increasing antitumor activity of chemotherapeutic agents' [patent_app_type] => utility [patent_app_number] => 11/120644 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14584 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244335.pdf [firstpage_image] =>[orig_patent_app_number] => 11120644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259121 [patent_doc_number] => 20070212753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Altered antibodies and their preparation' [patent_app_type] => utility [patent_app_number] => 11/114233 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 9142 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212753.pdf [firstpage_image] =>[orig_patent_app_number] => 11114233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886309 [patent_doc_number] => 20080260641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Human Monoclonal Antibodies Against Cd20' [patent_app_type] => utility [patent_app_number] => 11/578818 [patent_app_country] => US [patent_app_date] => 2005-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 29242 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260641.pdf [firstpage_image] =>[orig_patent_app_number] => 11578818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 133235 [patent_doc_number] => 07696307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Function and regulation of ADAMTS-1' [patent_app_type] => utility [patent_app_number] => 11/104075 [patent_app_country] => US [patent_app_date] => 2005-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21427 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696307.pdf [firstpage_image] =>[orig_patent_app_number] => 11104075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33112 [patent_doc_number] => 07785903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Variable domain library and uses' [patent_app_type] => utility [patent_app_number] => 11/102502 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 36582 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785903.pdf [firstpage_image] =>[orig_patent_app_number] => 11102502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4456916 [patent_doc_number] => 07893216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Anti-human trail receptor DR5 monoclonal antibody (AD5-10), method thereof and use of the same' [patent_app_type] => utility [patent_app_number] => 11/596271 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4352 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893216.pdf [firstpage_image] =>[orig_patent_app_number] => 11596271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225017 [patent_doc_number] => 20070254283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Brhf1 as a Cancer Diagnostic Marker' [patent_app_type] => utility [patent_app_number] => 10/591726 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20320 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254283.pdf [firstpage_image] =>[orig_patent_app_number] => 10591726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225051 [patent_doc_number] => 20070254317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Method for Detecting the Activatable Free Form of Psa and the Use Thereof for Diagnosing Benign Pathologies of the Prostate and Adenocarcinoma of the Prostate' [patent_app_type] => utility [patent_app_number] => 10/590272 [patent_app_country] => US [patent_app_date] => 2005-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10976 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254317.pdf [firstpage_image] =>[orig_patent_app_number] => 10590272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830281 [patent_doc_number] => 07399835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/067366 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6949 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399835.pdf [firstpage_image] =>[orig_patent_app_number] => 11067366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7182835 [patent_doc_number] => 20050191306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/067390 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6139 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191306.pdf [firstpage_image] =>[orig_patent_app_number] => 11067390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243241 [patent_doc_number] => 20050271630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Method for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/059408 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5272 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271630.pdf [firstpage_image] =>[orig_patent_app_number] => 11059408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476445 [patent_doc_number] => 20100285004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Anti-CD38 human antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/588568 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16504 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285004.pdf [firstpage_image] =>[orig_patent_app_number] => 10588568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476445 [patent_doc_number] => 20100285004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Anti-CD38 human antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/588568 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16504 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285004.pdf [firstpage_image] =>[orig_patent_app_number] => 10588568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 435773 [patent_doc_number] => 07262028 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Recombinant production of mixtures of antibodies' [patent_app_type] => utility [patent_app_number] => 11/039767 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 32 [patent_no_of_words] => 34070 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262028.pdf [firstpage_image] =>[orig_patent_app_number] => 11039767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7039345 [patent_doc_number] => 20050158779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'PG-3 and biallelic markers thereof' [patent_app_type] => utility [patent_app_number] => 11/028971 [patent_app_country] => US [patent_app_date] => 2005-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 85326 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158779.pdf [firstpage_image] =>[orig_patent_app_number] => 11028971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432645 [patent_doc_number] => 07968690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Agonist anti-trkC antibodies and methods using same' [patent_app_type] => utility [patent_app_number] => 10/584443 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29546 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968690.pdf [firstpage_image] =>[orig_patent_app_number] => 10584443 [rel_patent_id] =>[rel_patent_doc_number] =>)